XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/uncategorized/newsarena-completes-apd811-phase-ib-clinical-trial-pulmonary-arterial-hypertension/20%Daily2013-08-29 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspfizer-completes-pneumonia-case-accrual-capita-trial-prevenar-13/20%Daily2013-08-29 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsoncogenex-begins-enrolment-rainier-phase-ii-pancreatic-cancer-trial/20%Daily2013-08-28 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsastars-gis-researchers-discover-neurogenesis-controlling-long-non-coding-rna/20%Daily2013-08-28 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscongenia-begins-enrolling-healthy-volunteers-phase-i-trial-gnx-5086/20%Daily2013-08-27 17:30
https://www.clinicaltrialsarena.com/uncategorized/newslipidor-announces-positive-results-from-phase-iiia-psoriasis-study/20%Daily2013-08-27 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgsk-phase-iii-crohns-disease-study-vercirnon-fails-meet-end-points/20%Daily2013-08-26 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstakeda-zinfandel-begin-phase-iii-trial-low-dose-pioglitazone/20%Daily2013-08-26 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsisco-duke-university-sign-clinical-research-deal-for-parkinsons-disease/20%Daily2013-08-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscatabasis-begins-phase-ii-trial-of-cat-2003-for-hypertriglyceridemia-hypercholesterolemia/20%Daily2013-08-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsincyte-reports-results-from-phase-ii-proof-of-concept-trial-of-ruxolitinib/20%Daily2013-08-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsotonomy-reports-positive-phase-ib-data-of-oto-201-in-children-undergoing-ear-tube-placement-surgery/20%Daily2013-08-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmacrogenics-begins-patient-dosing-in-phase-i-dose-expansion-cohort-trial-of-mga271/20%Daily2021-11-25 11:38
https://www.clinicaltrialsarena.com/uncategorized/newsadimab-innovent-partner-for-antibody-based-therapeutic-discovery-programme/20%Daily2013-08-20 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsprecisions-prospective-trial-shows-65-overall-survival-in-recurrent-ovarian-cancer-patients/20%Daily2013-08-19 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsselexys-commences-sustain-phase-ii-trial-of-selg1-in-sickle-cell-patients-with-pain-crises/20%Daily2013-08-19 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsdyax-commences-dosing-in-phase-i-study-of-dx-2930/20%Daily2013-08-18 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsprosonix-completes-patient-dosing-in-phase-ii-study-of-psx1002/20%Daily2013-08-18 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsligand-signs-deal-with-curx-to-develop-captisol-enabled-topiramate-injection/20%Daily2013-08-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsseattle-commences-phase-ii-trial-of-adcetris-for-diffuse-large-b-cell-lymphoma/20%Daily2013-08-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/news-acasti-positive-data-trial-hypertriglyceridemia-candidate/20%Daily2013-08-14 17:30
https://www.clinicaltrialsarena.com/uncategorized/news-transtech-positive-trial-data-diabetes-drug/20%Daily2013-08-14 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsamarantus-manf-retinitis-pigmentosa/20%Daily2013-08-13 17:30
https://www.clinicaltrialsarena.com/uncategorized/newseli-lilly-phaseiii-necitumumab/20%Daily2013-08-13 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnuevolution-enters-scientific-partnership-with-duke-university-howard-hughes-lexicon/20%Daily2013-08-12 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstekmira-begins-phase-iii-study-of-rnai-oncology-therapeutic/20%Daily2013-08-12 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsus-sets-up-two-research-consortia-for-ptsd-and-mtbi/20%Daily2013-08-11 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsberg-us-department-of-defense-partner-for-prostate-cancer-research/20%Daily2013-08-11 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsrexahn-pharmaceuticals-commences-dosing-phase-i-trial-cancer-drug/20%Daily2013-08-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsthreshold-commences-phase-ii-trial-of-investigational-hypoxia-targeted-drug/20%Daily2013-08-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnovartis-afinitor-phase-iii-trial-fails-to-meet-primary-end-point/20%Daily2013-08-07 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsisis-reports-data-from-phase-ii-study-of-isis-crp-in-rheumatoid-arthritis/20%Daily2013-08-06 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsbayer-compugen-partner-develop-new-cancer-immunotherapy/20%Daily2013-08-05 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssanofi-pasteur-begins-phase-iii-study-investigational-clostridium-difficile-vaccine/20%Daily2013-08-05 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgw-pharmaceuticals-reports-results-from-multiple-sclerosis-spasticity-study-of-sativex/20%Daily2013-08-04 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspaciras-exparel-phase-iii-trial-fails-to-meet-primary-endpoint/20%Daily2013-08-04 17:30
https://www.clinicaltrialsarena.com/uncategorized/news-pharmanest-phase-ii-study-shact-efficacy/20%Daily2013-08-01 17:30
https://www.clinicaltrialsarena.com/uncategorized/news-viropharma-terminate-phase-ii-study-cinryze/20%Daily2013-08-01 17:30